These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6508252)

  • 41. [Rapid method of determination of sensitivity of Vibrio cholerae to antibiotics].
    Donskaia TN
    Lab Delo; 1976; (6):381. PubMed ID: 61330
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antibiotic sensitivity of strains of nonagglutinating vibrios and El Tor vibrios].
    Ziiaev ShI; Dzhalilov KD; Satybaldieva NSh
    Antibiotiki; 1979 Feb; 24(2):105. PubMed ID: 155421
    [No Abstract]   [Full Text] [Related]  

  • 43. [The composition of a population of cloned cultures of revertant Vibrio cholerae L forms].
    Danilkina EB; Lomov IuM; Kolesnikov NN; Lobanov VV; Vlasov VP; Cherkasova LR; Badalova IM
    Mikrobiol Zh (1978); 1990; 52(3):10-6. PubMed ID: 2215283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Seasonal fluctuations in the antibiotic sensitivity of Vibrio cholerae].
    Andrusenko IT; Pasternak NA; Givental' NI; Ved'mina EA; Shepelev AP
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):275-9. PubMed ID: 3631933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of in vitro activity of mecillinam with other antimicrobial chemotherapeutic agents against Salmonella Shigella and El Tor Vibrio cholerae.
    Mhalu FS; Swai V; Runyoro D; Shao JF
    East Afr Med J; 1982 Oct; 59(10):676-81. PubMed ID: 6309499
    [No Abstract]   [Full Text] [Related]  

  • 46. The in vitro sensitivity of Bibrio Cholerae strains to sulfamethopyrazine and aminosidine and data on the transfer of drug resistance from E. coli to some cholera agent strains.
    Ruiz Merino J; Buogo A
    Farmaco Prat; 1973 Apr; 28(4):210-7. PubMed ID: 4572388
    [No Abstract]   [Full Text] [Related]  

  • 47. [Responses of E1 Tor cholera Vibrio to antibiotics in relation to intestinal flora: antibiotic sensitivity and behaviors in mixed culture with resistant E. coli].
    Kino I
    Nihon Ika Daigaku Zasshi; 1983 Oct; 50(5):702-15. PubMed ID: 6363444
    [No Abstract]   [Full Text] [Related]  

  • 48. [Development of multiple antibiotic resistance in vivo in cholera vibrions].
    Podosinnikova LS; Domoradskii IV
    Antibiotiki; 1973 May; 18(5):449-53. PubMed ID: 4781216
    [No Abstract]   [Full Text] [Related]  

  • 49. [Isolation and characteristics of polymyxin-resistant mutants of Shigella flexneri].
    Marakusha BI
    Antibiotiki; 1980 Oct; 25(10):753-8. PubMed ID: 6252826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Properties of a transferable resistance factor in Vibrio cholerae biotype eltor].
    Rahal K; Gerbaud GR; Chabbert YA
    Ann Microbiol (Paris); 1973 Oct; 124(3):283-94. PubMed ID: 4599373
    [No Abstract]   [Full Text] [Related]  

  • 51. Experimental development of antibiotic resistance in Vibrio cholerae.
    Dastidar SG; Chakrabarty A; Mozumdar A; Chakrabarty AN
    Indian J Med Res; 1976 Jul; 64(7):992-1000. PubMed ID: 992839
    [No Abstract]   [Full Text] [Related]  

  • 52. Dietary Isothiocyanates, Sulforaphane and 2-Phenethyl Isothiocyanate, Effectively Impair
    Krause K; Pyrczak-Felczykowska A; Karczewska M; Narajczyk M; Herman-Antosiewicz A; Szalewska-Pałasz A; Nowicki D
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638525
    [No Abstract]   [Full Text] [Related]  

  • 53. [Study of C1. perfringens resistance to lincomycin].
    Miasnikova LG
    Antibiotiki; 1976 Feb; 21(2):138-41. PubMed ID: 179463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [EFFECT OF OSMOTIC AND OXIDATIVE STRESS ON STRAINS OF GENOVARIANTS OF VIBRIO CHOLERAE EL TOR BIOVAR].
    Zadnova SP; Plekhanov NA; Krepostnova IM; Erokhin PS; Smirnova NI
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):55-62. PubMed ID: 26950990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chromosome markers of drug resistance as the selectors of potential vaccinal strains].
    Bondarenko VM; Marakusha BI
    Antibiotiki; 1984 Feb; 29(2):124-6. PubMed ID: 6367629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and properties of certain auxotrophic mutants of Vibrio cholerae E1 Tor.
    Martinevskii IL; Stogova AG
    Sov Genet; 1974 Nov; 9(1):64-7. PubMed ID: 4476928
    [No Abstract]   [Full Text] [Related]  

  • 57. Synergistic interaction of baker's yeast and iron in the enhancement of bacterial virulence.
    Joó I; Emöd J; Takács K
    Acta Microbiol Hung; 1984; 31(3):197-206. PubMed ID: 6393682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repositioning of a mucolytic drug to a selective antibacterial against Vibrio cholerae.
    Chung IY; Kim BO; Jang HJ; Cho YH
    J Microbiol; 2020 Jan; 58(1):61-66. PubMed ID: 31898254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmid-encoded multiple antibiotic resistance in Vibrio cholerae El Tor from Bangladesh.
    Threlfall EJ; Rowe B; Huq I
    Lancet; 1980 Jun; 1(8180):1247-8. PubMed ID: 6104055
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pathogenetic therapy of the intoxication caused by the endotoxin of the cholera of the El Tor vibrio].
    Dzhaparidze MN; Martens LA; Egorova VD; Ogarenko NB
    Patol Fiziol Eksp Ter; 1973; 17(5):75-8. PubMed ID: 4789468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.